|
1
|
Kanavos P: The rising burden of cancer in
the developing world. Ann Oncol Suppl. 8:viii15–viii23
|
|
2
|
Sun X, Qin S, Fan C, Xu C, Du N and Ren H:
Let-7: A regulator of the ERα signaling pathway in human breast
tumors and breast cancer stem cells. Oncol Rep. 29:2079–2087.
2013.PubMed/NCBI
|
|
3
|
Assi HA, Khoury KE, Dbouk H, Khalil LE,
Mouhieddine TH and El Saghir NS: Epidemiology and prognosis of
breast cancer in young women. J Thorac Dis. 5(Suppl 1): S2–S8.
2013.PubMed/NCBI
|
|
4
|
Ohno S, Takanashi M, Sudo K, Ueda S,
Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, et
al: Systemically injected exosomes targeted to EGFR deliver
antitumor microRNA to breast cancer cells. Mol Ther. 21:185–191.
2013. View Article : Google Scholar :
|
|
5
|
Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y,
Cong H, Wang X, Qiu W and Yue L: MiR-200b expression in breast
cancer: a prognostic marker and act on cell proliferation and
apoptosis by targeting Sp1. J Cell Mol Med. 19:760–769. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu FJ, Wang XB and Cao AG: Screening and
functional analysis of a differential protein profile of human
breast cancer. Oncol Lett. 7:1851–1856. 2014.PubMed/NCBI
|
|
7
|
Iglesias-Bartolome R, Patel V, Cotrim A,
Leelahavanichkul K, Molinolo AA, Mitchell JB and Gutkind JS: mTOR
inhibition prevents epithelial stem cell senescence and protects
from radiation-induced mucositis. Cell Stem Cell. 11:401–414. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castilho RM, Squarize CH, Chodosh LA,
Williams BO and Gutkind JS: mTOR mediates Wnt-induced epidermal
stem cell exhaustion and aging. Cell Stem Cell. 5:279–289. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martelli AM, Evangelisti C, Follo MY,
Ramazzotti G, Fini M, Giardino R, Manzoli L, McCubrey JA and Cocco
L: Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target
of rapamycin signaling network in cancer stem cells. Curr Med Chem.
18:2715–2726. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsubara S, Ding Q, Miyazaki Y, Kuwahata
T, Tsukasa K and Takao S: mTOR plays critical roles in pancreatic
cancer stem cells through specific and stemness-related functions.
Sci Rep. 3:32302013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun X, Jiao X, Pestell TG, Fan C, Qin S,
Mirabelli E, Ren H and Pestell RG: MicroRNAs and cancer stem cells:
the sword and the shield. Oncogene. 33:4967–4977. 2014. View Article : Google Scholar
|
|
12
|
Hart PC, Mao M, de Abreu ALP,
Ansenberger-Fricano K, Ekoue DN, Ganini D, Kajdacsy-Balla A,
Diamond AM, Minshall RD, Consolaro ME, et al: MnSOD upregulation
sustains the Warburg effect via mitochondrial ROS and
AMPK-dependent signalling in cancer. Nat Commun. 6:60532015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dhar SK, Tangpong J, Chaiswing L, Oberley
TD and St Clair DK: Manganese superoxide dismutase is a
p53-regulated gene that switches cancers between early and advanced
stages. Cancer Res. 71:6684–6695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirsch HA, Iliopoulos D and Struhl K:
Metformin inhibits the inflammatory response associated with
cellular transformation and cancer stem cell growth. Proc Natl Acad
Sci USA. 110:972–977. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rupaimoole R, Han HD, Lopez-Berestein G
and Sood AK: MicroRNA therapeutics: principles, expectations, and
challenges. Chin J Cancer. 30:368–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24−/low/CD44+ breast
cancer-initiating cells to radiation. J Natl Cancer Inst.
98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Woodward WA, Chen MS, Behbod F, Alfaro MP,
Buchholz TA and Rosen JM: WNT/beta-catenin mediates radiation
resistance of mouse mammary progenitor cells. Proc Natl Acad Sci
USA. 104:618–623. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zielske SP, Spalding AC, Wicha MS and
Lawrence TS: Ablation of breast cancer stem cells with radiation.
Transl Oncol. 4:227–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dey-Guha I, Wolfer A, Yeh ACG, G Albeck J,
Darp R, Leon E, Wulfkuhle J, Petricoin EF III, Wittner BS and
Ramaswamy S: Asymmetric cancer cell division regulated by AKT. Proc
Natl Acad Sci USA. 108:12845–12850. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: the 4 R's of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rycaj K and Tang DG: Cancer stem cells and
radioresistance. Int J Radiat Biol. 90:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Delort L, Perrier S, Dubois V, Billard H,
Mracek T, Bing C, Vasson MP and Caldefie-Chézet F:
Zinc-α2-glycoprotein: a proliferative factor for breast cancer? In
vitro study and molecular mechanisms. Oncol Rep. 29:2025–2029.
2013.PubMed/NCBI
|
|
25
|
Sun X, Tang SC, Xu C, Wang C, Qin S, Du N,
Liu J, Zhang Y, Li X, Luo G, et al: DICER1 regulated let-7
expression levels in p53-induced cancer repression requires cyclin
D1. J Cell Mol Med. 19:1357–1365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oliveras-Ferraros C, Cufí S,
Vazquez-Martin A, Torres-Garcia VZ, Del Barco S, Martin-Castillo B
and Menendez JA: Micro(mi) RNA expression profile of breast cancer
epithelial cells treated with the anti-diabetic drug metformin:
induction of the tumor suppressor miRNA let-7a and suppression of
the TGFβ-induced oncomiR miRNA-181a. Cell Cycle. 10:1144–1151.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Henle SJ, Wang G, Liang E, Wu M, Poo MM
and Henley JR: Asymmetric PI(3,4,5)P3 and Akt signaling mediates
chemotaxis of axonal growth cones. J Neurosci. 31:7016–7027. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chung CY, Potikyan G and Firtel RA:
Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase
through the regulation of PAKa. Mol Cell. 7:937–947. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chavez KJ, Garimella SV and Lipkowitz S:
Triple negative breast cancer cell lines: one tool in the search
for better treatment of triple negative breast cancer. Breast Dis.
32:35–48. 2010.
|
|
31
|
Mirzayans R, Andrais B, Scott A, Wang YW
and Murray D: Ionizing radiation-induced responses in human cells
with differing TP53 status. Int J Mol Sci. 14:22409–22435. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cataldi A, Di Giacomo V, Rapino M, Zara S
and Rana RA: Ionizing radiation induces apoptotic signal through
protein kinase Cδ (delta) and survival signal through Akt and
cyclic-nucleotide response element-binding protein (CREB) in Jurkat
T cells. Biol Bull. 217:202–212. 2009.PubMed/NCBI
|
|
33
|
Landsverk KS, Lyng H and Stokke T: The
response of malignant B lymphocytes to ionizing radiation: cell
cycle arrest, apoptosis and protection against the cytotoxic
effects of the mitotic inhibitor nocodazole. Radiat Res.
162:405–415. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
McDermott SP and Wicha MS: Targeting
breast cancer stem cells. Mol Oncol. 4:404–419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suman S, Das TP and Damodaran C: Silencing
NOTCH signaling causes growth arrest in both breast cancer stem
cells and breast cancer cells. Br J Cancer. 109:2587–2596. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lombardo Y, Filipović A, Molyneux G,
Periyasamy M, Giamas G, Hu Y, Trivedi PS, Wang J, Yagüe E, Michel L
and Coombes RC: Nicastrin regulates breast cancer stem cell
properties and tumor growth in vitro and in vivo. Proc Natl Acad
Sci USA. 109:16558–16563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Z, Shi K, Guan L, Cao T, Jiang Q, Yang
Y and Xu C: ROS leads to MnSOD upregulation through ERK2
translocation and p53 activation in selenite-induced apoptosis of
NB4 cells. FEBS Lett. 584:2291–2297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi X, Zhang Y, Zheng J and Pan J:
Reactive oxygen species in cancer stem cells. Antioxid Redox
Signal. 16:1215–1228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ito K and Suda T: Metabolic requirements
for the maintenance of self-renewing stem cells. Nat Rev Mol Cell
Biol. 15:243–256. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Neumüller RA and Knoblich JA: Dividing
cellular asymmetry: asymmetric cell division and its implications
for stem cells and cancer. Genes Dev. 23:2675–2699. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dey-Guha I, Alves CP, Yeh AC, Salony, Sole
X, Darp R and Ramaswamy S: A mechanism for asymmetric cell division
resulting in proliferative asynchronicity. Mol Cancer Res.
13:223–230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lagadec C, Vlashi E, Della Donna L,
Dekmezian C and Pajonk F: Radiation-induced reprogramming of breast
cancer cells. Stem Cells. 30:833–844. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Printz C: Radiation treatment generates
therapy-resistant cancer stem cells from less aggressive breast
cancer cells. Cancer. 118:32252012.PubMed/NCBI
|
|
45
|
Wu L, Shao L, Li M, Zheng J, Wang J, Feng
W, Chang J, Wang Y, Hauer-Jensen M and Zhou D: BMS-345541
sensitizes MCF-7 breast cancer cells to ionizing radiation by
selective inhibition of homologous recombinational repair of DNA
double-strand breaks. Radiat Res. 179:160–170. 2013. View Article : Google Scholar :
|
|
46
|
Lai CH, Chang CS, Liu HH, Tsai YS, Hsu FM,
Yu YL, Lai CK, Gandee L, Pong RC, Hsu HW, et al: Sensitization of
radio-resistant prostate cancer cells with a unique cytolethal
distending toxin. Oncotarget. 5:5523–5534. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gu Q, He Y, Ji J, Yao Y, Shen W, Luo J,
Zhu W, Cao H, Geng Y, Xu J, et al: Hypoxia-inducible factor 1α
(HIF-1α) and reactive oxygen species (ROS) mediates
radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in
non-small cell lung carcinoma cells. Oncotarget. 6:10893–10907.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun X, Jiang S, Liu J, Wang H, Zhang Y,
Tang SC, Wang J, Du N, Xu C, Wang C, et al: MiR-208a stimulates the
cocktail of SOX2 and β-catenin to inhibit the let-7 induction of
self-renewal repression of breast cancer stem cells and formed
miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget.
6:32944–32954. 2015.PubMed/NCBI
|
|
49
|
Cruceru ML, Neagu M, Demoulin J-B and
Constantinescu SN: Therapy targets in glioblastoma and cancer stem
cells: lessons from haematopoietic neoplasms. J Cell Mol Med.
17:1218–1235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bartalucci N, Tozzi L, Bogani C,
Martinelli S, Rotunno G, Villeval JL and Vannucchi AM: Co-targeting
the PI3K/mTOR and JAK2 signalling pathways produces synergistic
activity against myeloproliferative neoplasms. J Cell Mol Med.
17:1385–1396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rosner M, Hanneder M, Siegel N, Valli A,
Fuchs C and Hengstschlager M: The mTOR pathway and its role in
human genetic diseases. Mutat Res. 659:284–292. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Britschgi A, Bill A, Brinkhaus H, Rothwell
C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, et al:
Calcium-activated chloride channel ANO1 promotes breast cancer
progression by activating EGFR and CAMK signaling. Proc Natl Acad
Sci USA. 110:E1026–E1034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou D, Shao L and Spitz DR: Reactive
oxygen species in normal and tumor stem cells. Adv Cancer Res.
122:1–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
